#Taiwan, As the #COVID19 #epidemic continues to rise, CDC calls the public to get vaccinated as soon as possible (June 30 '26)

 

    The Taiwan Centers for Disease Control (CDC) stated today (June 30) that the COVID-19 pandemic continues to rise both domestically and internationally, and with the summer travel season approaching, the risk of virus transmission is increasing. 

    The publicly funded COVID-19 vaccines currently used in Taiwan still provide protection against the existing circulating strains. 

    Those planning to travel who have not yet been vaccinated are encouraged to seize this opportunity to get vaccinated as soon as possible to obtain sufficient protection.

    According to CDC statistics, the COVID-19 pandemic is rising domestically. 

    In the 25th week (June 21-27), there were 1,452 outpatient and emergency room visits related to COVID-19, an increase of 43.8% compared to the previous week. 

    Last week (June 23-29), there were 8 new local cases of severe COVID-19 complications, with no new local deaths. 

    Since October 2025, there have been a cumulative total of 105 local cases of severe COVID-19 complications, of which 16 have died. 

    The majority of severe cases are among the elderly aged 65 and above (71.4%) and those with a history of chronic diseases (81.9%). 94.3% of these cases have not received the COVID-19 vaccine this season. 

    The global COVID-19 positivity rate has recently shown a slight increase, with a significant rise in the Western Pacific and Eastern Mediterranean regions. 

    Neighboring countries/regions such as China, Hong Kong, and Japan are experiencing rising cases, while South Korea's situation is fluctuating at a low point. 

    Currently, the predominant circulating variant globally is NB.1.8.1, followed by BA.3.2 and JN.1. 

    Neighboring countries such as China and Hong Kong have a higher proportion of NB.1.8.1. 

    Furthermore, as of June 28, 2026, approximately 1.728 million COVID-19 vaccinations have been administered this season, with vaccination rates among those aged 65 and above at 20.97% for the first dose and 0.48% for the second dose.

    The Taiwan Centers for Disease Control (CDC) reminds the public that the nationwide rollout of publicly funded COVID-19 vaccines to those who are 6 months (180 days) or older will continue until July 31st of this year. 

    Approximately 461,000 doses remain in stock (including 455,000 doses of the single-dose Moderna vaccine and 6,000 doses of the Novavax vaccine). 

    The public is urged to seize this opportunity and get vaccinated as soon as possible. 

    High-risk groups, such as those aged 65 and above, who have not yet been vaccinated or have received their first dose with a 6-month interval, are also urged to get vaccinated promptly to enhance their immune protection. 

    Furthermore, the multi-dose Moderna vaccine for young children has been exhausted. 

    Following discussions and approval by the Advisory Committee on Infectious Disease Prevention and Control (ACIP) of the Ministry of Health and Welfare on June 24th of this year, it has been agreed that for children aged 6 months to 11 years who require vaccination, the remaining doses of the single-dose Moderna vaccine (after deducting half the dose) can be used for their vaccination.

    The CDC urges the public not to be complacent about the ongoing global COVID-19 pandemic and to take necessary precautions such as frequent handwashing, wearing masks, and getting vaccinated. 

    Individuals with severe risk factors (such as those over 65 years of age, pregnant women, those with chronic diseases, or those with weakened immune systems) are at high risk of developing severe complications. 

    If they experience suspected symptoms, they should seek medical attention as soon as possible. 

    A doctor will assess their condition and prescribe antiviral medication to reduce the risk of severe complications or death after infection. 

    The public can also purchase home rapid testing kits at convenience stores or pharmacies that sell them for self-testing to facilitate subsequent medical diagnosis and treatment. 

    Currently, there are sufficient reserves of antiviral drugs. There are 113,000 doses of oral antiviral drugs (Beravir and Remdesivir) and 156,000 doses of injectable Remdesivir in stock. 

    Health bureaus in various counties and cities will manage and allocate resources according to the usage at each distribution point. The public can rest assured.

Source: 

Link: https://www.cdc.gov.tw/Bulletin/Detail/I6r18LGy_-Y1I2Fj72gO2w?typeid=9

____